Fulvia Farabegoli
Bologna, 40126, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity.
Journal: Cell death discovery
Published: October 14, 2024
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer.
Journal: European journal of medicinal chemistry
Published: October 27, 2023
Preomic profile of BxPC-3 cells after treatment with BRC4.
Journal: Journal of proteomics
Published: April 11, 2023
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination.
Journal: International journal of molecular sciences
Published: June 17, 2022
Epigallocatechin-3-Gallate (EGCG) Mitigates Endothelial and Circulating Cells Alterations Following PLLA Electrospun Mat Placement.
Journal: Biomedicines
Published: March 18, 2022
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells.
Journal: Biochimica et biophysica acta. General subjects
Published: February 08, 2022
Epigallocatechin-3-Gallate Delivery in Lipid-Based Nanoparticles: Potentiality and Perspectives for Future Applications in Cancer Chemoprevention and Therapy.
Journal: Frontiers in pharmacology
Published: November 05, 2021
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC).
Journal: Molecules (Basel, Switzerland)
Published: December 29, 2020
Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib.
Journal: Journal of medicinal chemistry
Published: February 11, 2020
Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells.
Journal: European journal of medicinal chemistry
Published: October 19, 2018
Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro.
Journal: Nutrients
Published: July 09, 2018
Last Updated: 09/26/2026